M P3 (Paroxetine Extended-Release 12.5 mg)

Pill imprint M P3 has been identified as Paroxetine hydrochloride extended-release 12.5 mg.

Paroxetine is used in the treatment of anxiety and stress; anxiety; depression; postmenopausal symptoms; hot flashes (and more), and belongs to the drug class selective serotonin reuptake inhibitors. Excluding Brisdelle: There is positive evidence of human fetal risk during pregnancy. Brisdelle: Not for use in pregnancy. Paroxetine 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Paroxetine hydrochloride extended-release

Imprint:

M P3

Strength:

12.5 mg

Color:

White

Size:

8.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Selective serotonin reuptake inhibitors

Pregnancy Category:

D - Positive evidence of risk - excluding Brisdelle
X - Not for use in pregnancy - Brisdelle

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-2003

Inactive Ingredients:

ferrosoferric oxide
silicon dioxide
hydroxypropyl cellulose (type h)
hypromelloses
lactose monohydrate
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
polydextrose
polyethylene glycol
polysorbate 80
propylene glycol
sodium hydroxide
magnesium silicate
titanium dioxide
triacetin
triethyl citrate

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
51079-0824	UDL Laboratories Inc
21695-0552	Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.